Trials / Completed
CompletedNCT04675814
Prospective Evaluation of the Impact on Patients' Quality of Life of a 12-Week Adapted Physical Activity Program (APA)
Prospective Evaluation of the Impact on Patients' Quality of Life of a 12-Week Adapted Physical Activity Program (APA) at Institut de Cancerologie de l'Ouest (ICO)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 37 (actual)
- Sponsor
- Institut Cancerologie de l'Ouest · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the effects of regular physical practice on fatigue, quality of life and kinesiophobia in patients treated at the ICO in Angers, regardless of the type of cancer and the type of treatment.
Detailed description
The objective of this study is to evaluate the effects of regular physical practice on fatigue, quality of life and kinesiophobia in patients treated at the ICO in Angers, regardless of the type of cancer and the type of treatment. A 12-week Adapted Physical Activity program (APA) is proposed to patients included in the study with an assessment of fatigue, quality of life, level of physical activity and kinesiophobia (fear of movement) at the beginning of the study. A second assessment of fatigue and quality of life will be done during the 6-week management. At the end of the program, a final evaluation of fatigue, quality of life and kinesiophobia will be done.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Adapted Physical Activity (APA) | Adults participating in the APA program at ICO during the first semester of 2020, regardless of cancer type and ongoing treatment (chemotherapy, radiotherapy, hormone therapy, immunotherapy). The APA program duration is : 12 weeks |
Timeline
- Start date
- 2020-09-14
- Primary completion
- 2021-03-14
- Completion
- 2021-03-14
- First posted
- 2020-12-19
- Last updated
- 2026-01-27
- Results posted
- 2026-01-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04675814. Inclusion in this directory is not an endorsement.